Pediatrix Medical Group, Inc.
General ticker "MD" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.6B (TTM average)
Pediatrix Medical Group, Inc. follows the US Stock Market performance with the rate: 45.6%.
Estimated limits based on current volatility of 1.5%: low 26.20$, high 26.99$
Factors to consider:
- Total employees count: 2150 as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Acquisition/divestiture risks, Strategic risks and growth management, Litigation risks, Key person loss
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [16.25$, 25.70$]
- 2026-12-31 to 2027-12-31 estimated range: [16.73$, 26.55$]
Financial Metrics affecting the MD estimates:
- Positive: with PPE of 10.7 at the end of fiscal year the price was neutral
- Positive: Operating cash flow per share per price, % of 14.62 > 13.08
- Positive: 7.80 < Operating profit margin, % of 10.91
- Positive: 18.97 < Shareholder equity ratio, % of 38.54 <= 42.26
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.86 > 6.06
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of 4.90 <= 5.56
- Positive: -4.49 < Investing cash flow per share per price, % of -0.99
Short-term MD quotes
Long-term MD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,994.64MM | $2,003.22MM | $1,913.85MM |
| Operating Expenses | $1,987.32MM | $2,071.93MM | $1,705.04MM |
| Operating Income | $7.32MM | $-68.71MM | $208.81MM |
| Non-Operating Income | $-55.68MM | $-32.63MM | $7.62MM |
| Interest Expense | $42.08MM | $40.74MM | $35.97MM |
| Income(Loss) | $-48.36MM | $-101.34MM | $216.43MM |
| Taxes | $12.05MM | $-2.27MM | $51.04MM |
| Net Income(Loss)* | $-60.41MM | $-99.07MM | $165.39MM |
| Stockholders Equity | $849.06MM | $764.94MM | $865.85MM |
| Assets | $2,219.81MM | $2,152.70MM | $2,246.70MM |
| Operating Cash Flow | $137.32MM | $206.57MM | $271.09MM |
| Capital expenditure | $33.33MM | $22.02MM | $18.46MM |
| Investing Cash Flow | $-48.18MM | $-35.41MM | $-18.30MM |
| Financing Cash Flow | $-25.71MM | $-14.48MM | $-107.49MM |
| Earnings Per Share** | $-0.73 | $-1.19 | $1.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.